References
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021;71:7-33.
- Rosiñol L, Beksac M, Zamagni E, Van de Donk NW, Anderson KC, Badros A, et al. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. Br J Haematol 2021. doi: 10.1111/ bjh.17338. Epub ahead of print.
- Billecke L, Penas EM, May AM, Engelhardt M, Nagler A, Leiba M, et al. Cytogenetics of extramedullary manifestations in multiple myeloma. Br J Haematol 2013;161:87-94.
- Rasche L, Bernard C, Topp MS, Kapp M, Duell J, Wesemeier C, et al. Features of extramedullary myeloma relapse: High proliferation, minimal marrow involvement, adverse cytogenetics: A retrospective single-center study of 24 cases. Ann Hematol 2012;91:1031-7.
- Shetty P, Lobo FD, Arvind R, Shetty SS. Oral extramedullary plasmacytoma in a HIV positive patient. Oral Oncol 2017;64:e4-5.
- Trivedi S, Dixit J, Goel MM. Extramedullary plasmacytoma of the gingiva. BMJ Case Rep 2016;2016:211606.
- Mumtaz S. Plasmacytoma. Oral Oncol 2018;82:196-7.
- Han JH, Woo YJ, Kang H, Kim JE. Primary extramedullary plasmacytoma mimicking oral lichen planus. Eur J Dermatol 2017;27:533-4.
- Basile FG, Shi M, Sullivan M. Solitary plasmacytoma of the uvula. Am J Hematol 2014;89:660-1.
- Lalla F, Vinciguerra A, Lissoni A, Arrigoni G, Luce FL, Abati S. Solitary extramedullary plasmacytoma presenting as asymptomatic palatal erythroplakia: Report of a case. Int J Environ Res Public Health 2021;18:3762.
- Raje N, Berdeja J, Lin Y, Siegel D, Jagannath S, Madduri D, et al. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N Engl J Med 2019;380:1726-37.
- Cohen AD, Garfall AL, Stadtmauer EA, Melenhorst JJ, Lacey SF, Lancaster E, et al. B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. J Clin Invest 2019;129:2210-21.